Have a personal or library account? Click to login
In Vitro Investigation of Potential Anti-Diabetic Activity of the Corm Extract of Hypoxis Argentea Harv. Ex Baker Cover

In Vitro Investigation of Potential Anti-Diabetic Activity of the Corm Extract of Hypoxis Argentea Harv. Ex Baker

Open Access
|Oct 2018

References

  1. 1. World Health Organization, The Burden of Chronic Diseases in the African Region, Preventing Chronic Diseases, A Vital Investment, World Diabetes Foundation Summit, WHO global report, Geneva 2007.
  2. 2. A. A. Motala, M. A. K. Omar and F. J. Pirie, Epidemiology of Diabetes in Africa, in The Epidemiology of Diabetes Mellitus (Eds. J. M. Ekoe, M. Rewers, R. Williams and P. Zimmet), 2nd ed., Wiley, Chichester 2008, pp. 133-146.10.1002/9780470779750.ch11
  3. 3. N. S. Levitt, Diabetes in Africa: epidemiology, management and health-care challenges, Heart 4 (2008) 1376-1382; https://doi.org/10.1136/hrt.2008.14730610.1136/hrt.2008.147306
  4. 4. C. N. He, C. L. Wang and S. X. Guo, Study on chemical constituents in herbs of Anoectochilus roxburghii II, China, J. Chin. Mat. Med. 30 (2005) 761-776.
  5. 5. M. Jung, M. Park, H. C. Lee, Y. Kang, E. S. Kang and S. K. Kim, Antidiabetic agents from medicinal plants, Curr. Med. Chem. 13 (2006) 1203-1218; https://doi.org/10.2174/09298670677636086010.2174/092986706776360860
  6. 6. S. O. Oyedemi, M. T. Yakubu and A. J. Afolayan, Antidiabetic activities of aqueous leaves extract of Leonotis leonurus in streptozotocin induced diabetic rats, J. Med. Plants Res. 5 (2011) 119-125.
  7. 7. N. Meliani, M. El Amine Dib, H. Allali and B. Tabti, Hypoglycaemic effect of Berberis vulgaris L. in normal and streptozotocin-induced diabetic rats, Asian Pac. J. Trop. Biomed. 1 ( 2011) 4 68-471; https://doi.org/10.1016/S2221-1691(11)60102-010.1016/S2221-1691(11)60102-0
  8. 8. S. O. Oyedemi, G. Bradley and A. J. Afolayan, Ethno-botanical survey of medicinal plants used for the management of diabetes mellitus in the Nkonkobe municipality of South Africa, J. Med. Plants Res. 3 (2009) 1040-1044.
  9. 9. V. D. P. Nair and I. Kanfer, A capillary zone electrophoresis method for the quantitative determination of hypoxoside in commercial formulations of African potato (Hypoxis hemerocallidea), Phytochem. Anal. 18 (2007) 475-483; https://doi.org/10.1002/pca.100310.1002/pca.100317624891
  10. 10. S. E. Drewes, E. Elliot, F. Khan, J. T. B. Dhlamini and M. S. S. Gcumisa, Hypoxis hemerocallidea -not merely a cure for benign prostate hyperplasia, J. Ethnopharmacol. 119 (2008) 593-598; https:// doi.org/10.1016/j.jep.2008.05.02710.1016/j.jep.2008.05.02718602776
  11. 11. J. A. O. Ojewole, Anti-nociceptive, anti-inflammatory and anti-diabetic properties of Hypoxis hermerocallidea Fisch. & C.A. Mey (Hypoxidaceae) corm [‘African Potato’] aqueous extract in mice and rats, J. Ethnopharmacol. 103 (2006) 126-134; https://doi.org/10.1016/j.jep.2005.07.01210.1016/j.jep.2005.07.01216191469
  12. 12. A. Vetere, A. Choudhary, S. M. Burns and B. K. Wagner, Targeting the pancreatic β-cell to treat diabetes, Nat. Rev. 13 (2014) 278-289; https://doi.org/10.1038/nrd423110.1038/nrd423124525781
  13. 13. M. Feoktistova, P. Geserick and M. Leverkus, Crystal violet assay for determining the viability of cultured cells, Cold Spring Harb. Protoc. 2016; https://doi.org/ 1101/pdb.prot 08737910.1101/pdb.prot08737927037069
  14. 14. M. S. Deutschlander, M. Van de Venter, S. Roux, J. Louw and N. Lall, Hypoglycemic activity of four plant extracts traditionally used in South Africa in diabetes, J. Ethnopharmacol. 124 (2009) 619-624; https://doi.org/ 10.1016/j.jep.2009.04.05210.1016/j.jep.2009.04.05219422900
  15. 15. J. L. Ramirez-Zacarias, F. Castro-Mufiozledo and W. Kuri-Harcuch, Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with oil red O, Histochemistry 97 (1997) 493-497.10.1007/BF003160691385366
  16. 16. L. G. Ranilla, Y. I. Kwon, E. Apostolidis and K. Shetty, Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America, Bioresour. Technol. 101 (2010) 4676-4689; https://doi.org/ 10.1016/j.biortech.2010.01.09310.1016/j.biortech.2010.01.09320185303
  17. 17. M. Al-Masri, M. K. Mohammad and M. O. Tahaa, Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine, J. Enzyme Inhib. Med. Chem. 24 (2009) 1061-1066; https://doi.org/10.1080/1475636080261076110.1080/1475636080261076119640223
  18. 18. S. Schmidt, M. Jakab, S. Jav, D. Streif, A. Pitchmann, M. Zehl, S. Purevsuren, S. Glasl and M. Ritter, Extracts from Leonurus sibiricus L. increase insulin secretion and proliferation of rat INS-1E insulinoma cells, J. Ethnopharmacol. 150 (2013) 85-94; https://doi.org/10.1016/j.jep.2013.08.01310.1016/j.jep.2013.08.01323978659
  19. 19. D. Liu, W. Zhen, Z. Yang, J. D. Carter, H. Si and K. A. Reynolds, Genistein acutely stimulates insulin secretion in pancreatic β cells through a cAMP-dependent protein kinase pathway, Diabetes 55 (2006) 1043-1050.10.2337/diabetes.55.04.06.db05-108916567527
  20. 20. T. Lapidot, M. D. Walker and J. Kanner, Antioxidant and pro-oxidant effects of phenolics on pancreatic β-cells in vitro, J. Agric. Food Chem. 50 (2002) 7220-7225; https://doi.org/10.1021/jf020615a10.1021/jf020615a12452635
  21. 21. M. Pinent, A. Castell, I. Baiges, G. Montagut, L. Arola and A. Ardevol, Bioactivity of flavonoids on insulin-secreting cells, Comp. Rev. Food Sci. Food Safety 7 (2008) 299-308; https://doi.org/10.1111/j. 1541-4337.2008.00048.x10.1111/j.1541-4337.2008.00048.x
  22. 22. E. M. Van Dam, R. Govers and D. E. James, Activation is required at a late stage of insulin-induced GLUT-4 translocation to the plasma membrane, Mol. Endocrinol. 19 (2005) 1067-1077; https://doi.org/10.1210/me.2004-041310.1210/me.2004-041315650020
  23. 23. I. M. Mahomed and J. A. Ojewole, Hypoglycemic effect of Hypoxis hemerocallidea corm (African potato) aqueous extract in rats, Methods Find. Exp. Clin. Pharmacol. 25 (2003) 617-623; https://doi.org/10.1358/mf.2003.25.8.77808210.1358/mf.2003.25.8.77808214671679
  24. 24. S. Oyedemi, T. Koekemoer, G. Bradley, M. Van de Venter and A. Afolayan, In vitro anti-hyperglycemia properties of the aqueous stem bark extract from Strychnos henningsii (Gilg), Int. J. Diabetes Dev. C. 33 (2013) 120-127; https://doi.org/10.1007/s13410-013-0120-810.1007/s13410-013-0120-8
  25. 25. V. Rizzati, F. Boschi, M. Pedrotti, E. Zoico, A. Sharbati and M. Zamboni, Lipid droplets characterization in adipocyte differentiated 3T3-L1 cells: size and optical density distribution, Eur. J. Histochem. 57 (2013) 159-162; https://doi.org/10.4081/ejh.2013.e2410.4081/ejh.2013.e24379435524085273
  26. 26. S.-J. Kim and S-Y. Choung, Inhibitory effects of Aster spathulifolius extract on adipogenesis and lipid accumulation in 3T3-L1 pre-adipocytes, J. Pharm. Pharmacol. 68 (2016) 107-118; https://doi.org/10.1111/jphp.1248510.1111/jphp.12485
  27. 27. M. Lonn, K. Mehlig, C. Bengtsson and L. Lissner, Adipocyte size predicts incidence of type 2 diabetes in women, FASEB J. 24 (2010) 326-331; https://doi.org/10.1096/fj.09-13305810.1096/fj.09-133058
  28. 28. A. J. Alonso-Castro and L. A. Salazar-Olivo, The anti-diabetic properties of Gazuma ulmifolia Lam. are mediated by the stimulation of glucose uptake in normal and diabetic adipocytes without inducing adipogenesis, J. Ethnopharmacol. 118 (2008) 252-256; https://doi.org/10.1016/j.jep.2008.04.00710.1016/j.jep.2008.04.007
  29. 29. E. D. Abel, O. Peroni, J. A. Kim, Y. B. Kim, O. Boss, E. Hadro, T. Minnemann, G. I. Shulman and B. B. Kahn, Adipose-selective targeting of the GLUT 4 gene impairs insulin action in muscle and liver, Nature 409 (2001) 729-733; https://doi.org/10.1038/3505557510.1038/35055575
  30. 30. N. Fabre, I. Rustan, E. de Hoffmann and J. Quetin-Leclercq, Determination of flavone, flavonol and flavanone aglycones by negative ion liquid chromatography electrospray ion trap mass spectrometry. J. Am. Soc. Mass Spectrom. 12 (2001) 707-715; https://doi.org/10.1016/S1044-0305(01)00226-410.1016/S1044-0305(01)00226-4
  31. 31. L. A. Abdulkhaleg, M. A. Assi, M. H. M Noor, R. Abdullah, M. Z. Saad and Y. H. Taufig-Yap, Therapeutic uses of epicatechin in diabetes and cancer, Vet World 10 (2017) 869-872; https://doi.org/10.14202/vetworld.2017.869-87210.14202/vetworld.2017.869-872559147128919675
  32. 32. A. Arya, M. M. Al-Obaidi, N. Shahid, M. I. Bin Noordin, C. Y. Looi, W. F. Wong, S. L. Khaing and M. R. Mustafa, Synergistic effect of quercetin and quinic acid by alleviating structural degeneration in the liver, kidney and pancreas tissues of STZ-induced diabetic rats: a mechanistic study, Food Chem. Toxicol. 71 (2014) 183-196; https://doi.org/10.1016/j.fct.2014.06.01010.1016/j.fct.2014.06.01024953551
  33. 33. C. Bucolo, K. W. Ward, E. Mazzon, S. Cuzzocrea and F. Drago, Protective effects of a coumarin derivative in diabetic rats, Invest. Ophthalmol. Vis. Sci. 50 (2009) 3846-3852; https://doi.org/10.1167/iovs.08-332810.1167/iovs.08-332819279317
DOI: https://doi.org/10.2478/acph-2018-0023 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 389 - 407
Submitted on: Aug 10, 2018
Accepted on: Feb 27, 2018
Published on: Oct 3, 2018
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2018 Akinleye Akinrinde, Trevor Koekemoer, Maryna Van De Venter, Graeme Bradley, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.